PMID- 36804969
OWN - NLM
STAT- MEDLINE
DCOM- 20230509
LR  - 20230509
IS  - 1530-891X (Print)
IS  - 1530-891X (Linking)
VI  - 29
IP  - 5
DP  - 2023 May
TI  - Effectiveness of Wearable Activity Monitors on Metabolic Outcomes in Patients 
      With Type 2 Diabetes: A Systematic Review and Meta-Analysis.
PG  - 368-378
LID - S1530-891X(23)00046-0 [pii]
LID - 10.1016/j.eprac.2023.02.004 [doi]
AB  - OBJECTIVE: Wearable activity monitors are promising tools for improving metabolic 
      outcomes in patients with type 2 diabetes mellitus (T2DM); however, no uniform 
      conclusive evidence is available. This study aimed to evaluate the effects of the 
      intervention using wearable activity monitors on blood glucose, blood pressure, 
      blood lipid, weight, waist circumference, and body mass index (BMI) in 
      individuals with T2DM. METHODS: Two independent reviewers searched 4 online 
      databases (PubMed, Cochrane Library, Web of Science, and Embase) to identify 
      relevant studies published from January 2000 to October 2022. The primary outcome 
      indicator was hemoglobin A1c (HbA1c), and the secondary outcome indicators 
      included physical activity (steps per day), fasting blood glucose, triglyceride, 
      high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total 
      cholesterol, systolic blood pressure, diastolic blood pressure, BMI, waist 
      circumference, and weight. RESULTS: A total of 25 studies were included. The 
      HbA1c level (standardized mean difference [SMD], -0.14; 95% confidence interval 
      [CI], -0.27 to -0.02; P = .02; I(2) = 48%), BMI (SMD, -0.16; 95% CI, -0.26 
      to -0.05; P = .002; I(2) = 0), waist circumference (SMD, -0.21; 95% CI, -0.34 
      to -0.09; P < .001; I(2) = 0), and steps/day (SMD, 0.55; 95% CI, 0.36-0.94; P < 
      .001; I(2) = 77%) significantly improved. CONCLUSION: Wearable activity 
      monitor-based interventions could facilitate the improvement of the HbA1c level, 
      BMI, and waist circumference and increase in physical activity in individuals 
      with T2DM. Wearable technology appeared to be an effective tool for the 
      self-management of T2DM; however, there is insufficient evidence about its 
      long-term effect.
CI  - Copyright (c) 2023 AACE. Published by Elsevier Inc. All rights reserved.
FAU - Peng, Ping
AU  - Peng P
AD  - Department of Endocrinology and Metabolism, the Second Affiliated Hospital of 
      Nanchang University, Nanchang, China; Institute for the Study of Endocrinology 
      and Metabolism in Jiangxi Province, Nanchang, China; Branch of National Clinical 
      Research Center for Metabolic Diseases, Nanchang, China.
FAU - Zhang, Neng
AU  - Zhang N
AD  - Department of Endocrinology and Metabolism, the Second Affiliated Hospital of 
      Nanchang University, Nanchang, China; Institute for the Study of Endocrinology 
      and Metabolism in Jiangxi Province, Nanchang, China; Branch of National Clinical 
      Research Center for Metabolic Diseases, Nanchang, China.
FAU - Huang, Jingjing
AU  - Huang J
AD  - Department of Endocrinology and Metabolism, the Second Affiliated Hospital of 
      Nanchang University, Nanchang, China; Institute for the Study of Endocrinology 
      and Metabolism in Jiangxi Province, Nanchang, China; Branch of National Clinical 
      Research Center for Metabolic Diseases, Nanchang, China.
FAU - Jiao, Xiaojuan
AU  - Jiao X
AD  - Department of Endocrinology and Metabolism, the Second Affiliated Hospital of 
      Nanchang University, Nanchang, China; Institute for the Study of Endocrinology 
      and Metabolism in Jiangxi Province, Nanchang, China; Branch of National Clinical 
      Research Center for Metabolic Diseases, Nanchang, China.
FAU - Shen, Yunfeng
AU  - Shen Y
AD  - Department of Endocrinology and Metabolism, the Second Affiliated Hospital of 
      Nanchang University, Nanchang, China; Institute for the Study of Endocrinology 
      and Metabolism in Jiangxi Province, Nanchang, China; Branch of National Clinical 
      Research Center for Metabolic Diseases, Nanchang, China. Electronic address: 
      syf92@live.com.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Systematic Review
DEP - 20230217
PL  - United States
TA  - Endocr Pract
JT  - Endocrine practice : official journal of the American College of Endocrinology 
      and the American Association of Clinical Endocrinologists
JID - 9607439
RN  - 0 (Glycated Hemoglobin)
RN  - 0 (Blood Glucose)
RN  - 0 (Cholesterol, HDL)
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2
MH  - Glycated Hemoglobin
MH  - Blood Glucose/analysis
MH  - Cholesterol, HDL
MH  - *Wearable Electronic Devices
OTO - NOTNLM
OT  - meta-analysis
OT  - systematic review
OT  - type 2 diabetes mellitus
OT  - wearable activity monitors
COIS- Disclosure The authors have no multiplicity of interest to disclose.
EDAT- 2023/02/23 06:00
MHDA- 2023/05/09 06:42
CRDT- 2023/02/22 09:13
PHST- 2022/11/18 00:00 [received]
PHST- 2023/02/08 00:00 [revised]
PHST- 2023/02/13 00:00 [accepted]
PHST- 2023/05/09 06:42 [medline]
PHST- 2023/02/23 06:00 [pubmed]
PHST- 2023/02/22 09:13 [entrez]
AID - S1530-891X(23)00046-0 [pii]
AID - 10.1016/j.eprac.2023.02.004 [doi]
PST - ppublish
SO  - Endocr Pract. 2023 May;29(5):368-378. doi: 10.1016/j.eprac.2023.02.004. Epub 2023 
      Feb 17.